COFCO Biotechnology Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 13,985.108 million compared to CNY 13,887.727 million a year ago. Operating income was CNY 707.149 million compared to CNY 496.223 million a year ago. Net income was CNY 533.746 million compared to CNY 389.164 million a year ago. Basic earnings per share from continuing operations was CNY 0.2887 compared to CNY 0.2106 a year ago. Diluted earnings per share from continuing operations was CNY 0.2883 compared to CNY 0.2106 a year ago.